These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31185007)

  • 41. Kinetics of thermal denaturation of human rhinoviruses in the presence of anti-viral capsid binders analyzed by capillary electrophoresis.
    Okun VM; Nizet S; Blaas D; Kenndler E
    Electrophoresis; 2002 Mar; 23(6):896-902. PubMed ID: 11920874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutathione facilitates enterovirus assembly by binding at a druggable pocket.
    Duyvesteyn HME; Ren J; Walter TS; Fry EE; Stuart DI
    Commun Biol; 2020; 3():9. PubMed ID: 31909201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
    Shepard DA; Heinz BA; Rueckert RR
    J Virol; 1993 Apr; 67(4):2245-54. PubMed ID: 8383239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
    Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
    Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The structure of coxsackievirus B3 at 3.5 A resolution.
    Muckelbauer JK; Kremer M; Minor I; Diana G; Dutko FJ; Groarke J; Pevear DC; Rossmann MG
    Structure; 1995 Jul; 3(7):653-67. PubMed ID: 8591043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species.
    Lanko K; Sun L; Froeyen M; Leyssen P; Delang L; Mirabelli C; Neyts J
    Antiviral Res; 2021 Nov; 195():105177. PubMed ID: 34517053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individual subunits of a rhinovirus causing common cold exhibit largely different protein-RNA contact site conformations.
    Blaas D
    Commun Biol; 2020 Sep; 3(1):537. PubMed ID: 32994533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
    Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hamiltonian path analysis of viral genomes.
    Twarock R; Leonov G; Stockley PG
    Nat Commun; 2018 May; 9(1):2021. PubMed ID: 29789600
    [No Abstract]   [Full Text] [Related]  

  • 50. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cryo-EM Structure of a Possum Enterovirus.
    Wang I; Gupta SK; Ems G; Jayawardena N; Strauss M; Bostina M
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The structure of human rhinovirus 16.
    Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
    Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
    Li Y; Zhou Z; Post CB
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7529-34. PubMed ID: 15899980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryo-EM structures reveal two distinct conformational states in a picornavirus cell entry intermediate.
    Shah PNM; Filman DJ; Karunatilaka KS; Hesketh EL; Groppelli E; Strauss M; Hogle JM
    PLoS Pathog; 2020 Sep; 16(9):e1008920. PubMed ID: 32997730
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses.
    Heinz BA; Vance LM
    J Virol; 1996 Jul; 70(7):4854-7. PubMed ID: 8676522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
    Li C; Wang H; Shih SR; Chen TC; Li ML
    Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assembly of infectious enteroviruses depends on multiple, conserved genomic RNA-coat protein contacts.
    Chandler-Bostock R; Mata CP; Bingham RJ; Dykeman EC; Meng B; Tuthill TJ; Rowlands DJ; Ranson NA; Twarock R; Stockley PG
    PLoS Pathog; 2020 Dec; 16(12):e1009146. PubMed ID: 33370422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses.
    Makarov VA; Braun H; Richter M; Riabova OB; Kirchmair J; Kazakova ES; Seidel N; Wutzler P; Schmidtke M
    ChemMedChem; 2015 Oct; 10(10):1629-34. PubMed ID: 26260222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insights into minor group rhinovirus uncoating: the X-ray structure of the HRV2 empty capsid.
    Garriga D; Pickl-Herk A; Luque D; Wruss J; Castón JR; Blaas D; Verdaguer N
    PLoS Pathog; 2012 Jan; 8(1):e1002473. PubMed ID: 22241997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.